The cost effectiveness of licensed oromucosal midazolam (Buccolam®) for the treatment of children experiencing acute epileptic seizures: an approach when trial evidence is limited
Authors:
Lee D, Gladwell D, Batty AJ, Brereton N and Tate E.
Publication type:
Journal article
Publication name:
Paediatric drugs
Citation:
Lee D, Gladwell D, Batty AJ, Brereton N and Tate E. The cost effectiveness of licensed oromucosal midazolam (Buccolam®) for the treatment of children experiencing acute epileptic seizures: an approach when trial evidence is limited. Paediatr Drugs. 2013; 15(2):151-62.
